
SPRY Market Capitalization Overview
Market Cap: $1.30B as of Jan 9, 2026
$1.30B
$309.40M (31.52%)past month
As of Jan 9, 2026, SPRY has a market capitalization of $1.30B. Over the past 30 days, its market cap has increased by 22.23%, while in the last 12 months, it has increased by 12.1%.
Market capitalization represents the total value of ARS Pharmaceuticals Inc as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
SPRY Market Cap Formula = Stock Price * Shares Outstanding
The market cap of SPRY helps investors assess the company's size and compare it with competitors for better investment decisions.
Market capitalization represents the total value of ARS Pharmaceuticals Inc as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
SPRY Market Cap Formula = Stock Price * Shares Outstanding
The market cap of SPRY helps investors assess the company's size and compare it with competitors for better investment decisions.
SPRY Market Cap & Key Trends
See ARS Pharmaceuticals Inc’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.
Start investing in SPRY
Order type
Buy in
Order amount
Est. shares
0 shares
SPRY Market Cap History
| Date | Market Cap | Change |
|---|---|---|
| Dec 1, 2025 | $929.18M | +9.07% |
| Nov 3, 2025 | $851.89M | -14.57% |
| Oct 1, 2025 | $997.16M | -9.26% |
| Sep 2, 2025 | $1.10B | -34.87% |
| Aug 1, 2025 | $1.69B | +6.77% |
| Jul 1, 2025 | $1.59B | +11.27% |
| Jun 2, 2025 | $1.43B | +2.22% |
| May 1, 2025 | $1.39B | +13.01% |
| Apr 1, 2025 | $1.23B | +24.27% |
| Mar 3, 2025 | $989.35M | -17.30% |
| Feb 3, 2025 | $1.20B | +14.94% |
| Jan 2, 2025 | $1.05B | -19.59% |
SPRY End of Year Market Cap History
| Date | Market Cap | Change |
|---|---|---|
| 2026 | $1.30B | +12.10% |
| 2025 | $1.16B | +12.32% |
| 2024 | $1.03B | +94.90% |
| 2023 | $526.07M | +71.04% |
| 2022 | $307.58M | +31.66% |
| 2021 | $233.61M | — |
FAQs About ARS Pharmaceuticals Inc (SPRY) Market Cap
As of Jan 9, 2026, the market capitalization of SPRY is $1.30B. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.
In the last 30 days, ARS Pharmaceuticals Inc’s market capitalization has increased by 31.52%, changing from $981.57M to $1.30B as of Jan 9, 2026.
In the last 3 months, ARS Pharmaceuticals Inc’s market capitalization has increased by —, changing from – to – as of –.
In the year 2025, ARS Pharmaceuticals Inc’s market capitalization increased from $1.03B in January to $1.16B in December, reflecting a 12.32% change.
In the past five years, SPRY has had a compound annual growth rate (CAGR) of 37.58% in market capitalization. This means its market cap has grown at an average rate of 37.58% per year.